Skip to Content Skip to Search

Sotrovimab for Injection

Prescription medicines

Sotrovimab for Injection

Product information:

Sotrovimab for Injection product monograph (PDF - 290 KB)

Patient information:

Important information (PDF - 103 KB) for patients

Health Product Risk Communications:

22 September 2021 - Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic (PDF - 510 KB)

14 April 2022 - Important Safety Information on Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of  SARS-CoV-2 Omicron BA.2 Subvariant (PDF - 581 KB)